Soleno Therapeutics (SLNO) Q4 2022 Earnings

21MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1.08
-0.91
-0.75
-0.58

Details

Expected EPS
-0.8
Actual EPS
-0.58
Surprise EPS
0.22
Surprise Percent
+27.5%

Description

Soleno Therapeutics (SLNO) has reported earnings of -0.58 per share for Q4 2022.

0 Comments

Share your thoughts